Extrahepatic bile duct malignancies.

INTRODUCTION: Biliary tract malignancies belong to very aggressive malignancies of the gastrointestinal tract. The only radical treatment is surgical resection which is possible only in a limited number of cases due to late diagnosis. The aim of this report was to present the experience of our own department with the diagnosis and treatment of these tumours. METHODS: In the years 2005-2021 radical (R0) resection was performed in 27 (28.4%) patients, the same number were managed only symptomatically and in 41 (43.2%) patients we used biliary stenting and external-internal drainage as the definitive procedure. Adjuvant oncological treatment was indicated in 16 (59.3%) of the radically operated and 49 (72.1%) of the non-operated patients. RESULTS: Median overall survival and median progression-free survival in the operated patients were 19.9 months and 15.7 months, respectively. Overall survival in the operated patients was significantly better (p.

Transhepatic perforation of the gallbladder with massive intraperitoneal hemorrhage as a rare complication of acute cholecystitis.

INTRODUCTION: Perforation of the gallbladder into the hepatic parenchyma with massive bleeding into the abdominal cavity is a very rare but life-threatening complication of acute cholecystitis. Initially, the clinical finding may not differ significantly from the normal course of acute cholecystitis, but later there is a significant deterioration associated with hemorrhagic shock. Monitoring of the patients clinical condition as well as radiological methods have a crucial role in early and accurate diagnosis. CASE REPORT: We present the case of a 55-year-old patient who was admitted to our clinic with the clinical finding of acute cholecystitis. During the third day of hospitalization, there was a significant deterioration in his clinical condition with circulatory instability. Computed tomography (CT) scans revealed massive hemoperitoneum with a large hematoma reaching into the liver parenchyma and the gallbladder bed. Based on this finding, the patient was indicated for urgent laparotomy. The perioperative finding confirmed intrahepatic perforation of the gallbladder with a stone collapsed into the hepatic parenchyma and secondary perforation of the hepatic capsule with massive bleeding into the abdominal cavity. The authors present an unusual complication of acute cholecystitis, its diagnosis and surgical solution. CONCLUSION: Massive intraperitoneal bleeding associated with transhepatic perforation of the gallbladder is very rare, occurring only in single-digit percent of acute cholecystitis cases. It is essential to evaluate not only the clinical and laboratory findings, but above all to complete an appropriate imaging assessment. The timing of the assessment is crucial for proper preoperative diagnosis and for reducing the risks of urgent surgical treatment.

Clear cell renal carcinoma metastases to the pancreas.

INTRODUCTION: To date, clear cell renal carcinoma (Grawitz tumour) remains the most frequent malignant tumour of the kidney in adults. It metastasises in more than 25% of cases, most frequently to the bones (osteolytic metastases), lungs, brain, liver, adrenal glands and the contralateral kidney. Metastases to the pancreas are rare and represent 1-4% of all malignant tumours of the pancreas. METHODS: This is a retrospective analysis of patients who were operated at the Department of Surgery in Pilsen between 2010 and 2018 for histologi-cally verified metastasis of clear cell carcinoma (Grawitz tumour) to the pancreas. RESULTS: We operated 12 patients (8 men and 4 women). The metastases appeared on average 8 years and 8 months following the primary urolo-gical surgery. The mean age of the male patients was 66.5 years and that of the female patients was 67.4 years. In our sample, the diagnostic specificity of the CT scan was 50%, the diagnostic specificity of endoscopic ultrasound (EUS) was 75% and subsequent EUS-guided fine needle aspiration biopsy performed in 100% of cases yielded a specificity of 75%. Resectability was 92%. The average length of hospitalisation was 11.5 days. Post-operative complications according to Clavien-Dindo were grade 1 in 66%, grade 2 in 1.25% and grade 5 in 8.3% of the cases. The 30-day post-operative mortality was 8.3% (one patient).  Conclusion: Clear cell renal carcinoma metastases to the pancreas are very rare. However, if radically removed, the patient has a good prognosis with regards to long-term survival.

Differentiated thyroid microcarcinoma current perspective.

INTRODUCTION: Differentiated thyroid cancer (DTC) has a good prognosis and low mortality despite its growing incidence, which is particularly the case of microcarcinomas (T1a - up to 10 mm). METHODS: Retrospective analysis of overall survival of patients in the group of thyroid gland surgeries for differentiated forms of microcarcinoma in the period of 2006-2015 up to the present. An overview of contemporary therapeutic methods is included. RESULTS: Thyroid cancer was detected in 144 cases out of the total of 1820 patients with thyreopathy undergoing surgery (8%); DTC microcarcinoma was detected in 65 cases (45.1%) of all carcinomas. The papillary form was diagnosed in 59 cases (51.8% of all papillary cases), and the follicular form was found in 6 cases (37.5% of all follicular cases). Two cases of Hürthle cells cancer were found, both in a stage higher than T1. Overall 10-year survival of carcinomas >T1 was 86%, reaching 90% in the microcarcinoma group (Gehan Wilcoxon test: p=0.10675). CONCLUSION: Differentiated microcarcinoma shows a very good overall survival. Provided that other criteria are satisfied, particularly unifocal occurrence without spreading through the gland casing and without any suspicion of nodal involvement, hemithyroidectomy is considered to be a sufficient procedure or the method of choice, respectively.

Radiofrequency ablation of colorectal liver metastases.

INTRODUCTION: Radical liver resection is the only method for the treatment of patients with colorectal liver metastases (CLM); however, only 20-30% of patients with CLMs can be radically treated. Radiofrequency ablation (RFA) is one of the possible methods of palliative treatment in such patients. METHODS: RFA was performed in 381 patients with CLMs between 01 Jan 2001 and 31 Dec 2018. The mean age of the patients was 65.2±8.7 years. The male to female ratio was 2:1. Open laparotomy was done in 238 (62.5%) patients and the CT-navigated transcutaneous approach was used in 143 (37.5%) patients. CLMs.

Therapy of liver cysts - experience of the Department of Surgery, University Hospital in Pilsen 20092018.

INTRODUCTION: Liver cysts are present in about 5% of the population and are asymptomatic in most cases. Currently, liver cystic lesions are disco-vered arbitrarily during imaging assessments of the abdomen indicated for unrelated reasons. The final findings vary from solitary cysts to multiple lesions or eventually the polycystic liver disease which can result in liver transplantation. Most cases are congenital. In the case of a symptomatic manifestation, pressure pain in the upper right quadrant is the predominant symptom. The therapy is surgical; laparoscopic approach is preferred. METHODS: A retrospective evaluation of the sample of 55 patients was conducted. The patients had been surgically treated at the Department of Surgery, University Hospital in Pilsen, from 01 Jan 2009 to 21 Dec 2017. The evaluation covered basic demographic data, the size of the dominant cyst, complications, hospitalization length, any relapse of the disease, etc. Results: In the presented period 62 surgeries of symptomatic liver cysts were performed, 55 of them by laparoscopy. The mean age of the patients was 61.7 years (32-83 years), women predominated (N=54, i.e. 87.1%). Complications occurred in 8 patients (12.9%); the most common was a bile leak. The mean length of hospitalisation was 4.5 days (2-20 days). In the follow-up period, 41 patients (66.1%) remained without any recidivism. CONCLUSION: Currently, the treatment of symptomatic liver cysts is laparoscopic, with fenestration being the standard approach. Due to potential complications centres with experience in liver surgery are prioritized.

Growth of colorectal liver metastases is not accelerated by intraportal administration of stem cells after portal vein embolization.

INTRODUCTION: Future liver remnant volume (FLRV) is a crucial factor impacting resectability of colorectal liver metastases (CLM). In case of low FLRV, augmentation can be done by performing portal vein embolization (PVE). However, there is a risk of progression of CLM between PVE and resection. Intraportal application of autologous hematopoietic stem cells (HSC) is a possibility to accelerate the growth of FLRV. The effect of thus applied SC on CLM progression still remains unclear, though. METHODS: 63 patients underwent PVE between 2003 and 2015. In 20 patients a product with HSC was applied intraportally on the first day after PVE (PVE HSC group). HSC were gained from peripheral blood (10 patients) or bone marrow (10 patients). FLRV and volume of liver metastases (VLM) were evaluated by CT volumetry. The gained data were statistically evaluated in relation to the disease free interval (DFI), overall survival (OS), achievement of CLM resectability and progression of extrahepatic metastases. We compared the PVE HSC group with the group of patient undergoing simple PVE. RESULTS: No significant difference in FLRV and VLM growth was observed between the study groups. The percentage of exploratory laparotomies was smaller in the group with PVE and HSC application. Patients with simple PVE had a significantly higher incidence of extrahepatic metastases during follow up. We did not observe any significant differences in DFI and OS between the groups. CONCLUSION: HSC application did not accelerate CLM growth in comparison with PVE alone. PVE and HSC application had a higher percentage of patients undergoing liver resection and a lower incidence of extrahepatic metastases.

[Liver Injury after a Collapse Caused by Acute Myocardial Infarction, Resuscitation and Acute Myocardial Revascularisation]. / Ruptura jater po kolapsu pri akutním infarktu myokardu, resuscitaci a akutní revaskularizaci myokardu.

The presented case report describes primarily an unrecognized liver injury after the resuscitation with cardiac massage due to myocardial infarction. After myocardial revascularization, the hemodynamic instability and anaemia in the patient persisted. The performed CT scan confirmed a liver injury, namely the rupture of liver parenchyma with hemoperitoneum, which had to be treated surgically. It represents a complication of cardiac massage that occurs, though less frequently. Key words: resuscitation, liver trauma.

Treatment of liver injuries at the Trauma Centre of the University Hospital in Pilsen.

INTRODUCTION: Traumatic liver injury is the most frequent cause of death due to traumatic bleeding in the peritoneal cavity. The progress of pre-hospital emergency medical service, improved surgical techniques, and advanced post-operative care decreased the morbidity from 65% to 10% over the last 40 years. The management is either surgical or non-surgical. Operation is indicated in case of haemodynamic instability and failure of non-surgical treatment. The aim of the paper is to evaluate the aetiology of liver injury, the type of treatment, and therapeutic results in patients hospitalized between 2006 and 2018 at the Trauma Centre of the University Hospital in Pilsen. METHODS: Our retrospective study includes 322 patients. Assessed characteristics: Type of injury (polytraumatic or monotraumatic), cause of trauma, trauma grade according to The American Association for the Surgery of Trauma, type of treatment, complications, mortality and the length of stay. RESULTS: There were 191 male and 131 female patients included in the study; 18.9% of these were children below the age of 16. Polytraumata represented 53.1%, multiple traumata 35.4% and monotraumata 11.5% of all injuries; 94.7% of patients had a blunt trauma of the liver and the most common reason of injury was traffic accident (57.8%). Conservative management was applied in 66.1% of all patients. The following surgical procedures were performed: liver packing (34 cases), exploration and drainage (10), liver resection (5), laparoscopy (7), radiofrequency ablation (3), cholecystectomy (2), and one case of bile duct revision. Thirty-day mortality was 7.7%. One patient died of bilateral pneumonia; the other non-surviving patients died of decompensated hemorrhagic shock or due to craniocerebral injury. CONCLUSION: Complex and centralized medical care of patients with liver trauma not only allows appropriate primary therapy, but it is also a precondition for the management of further specific complications.

[Liver hemangiomas - when is invasive treatment indicated?] / Hemangiomy jater - kdy indikovat invazivní lécbu?

INTRODUCTION: Liver hemangiomas are the most common benign tumors of the liver. Most are asymptomatic and are found accidentally by ultrasonography, computed tomography or magnetic resonance imaging of the abdomen. Liver hemangiomas usually do not need any treatment. Nevertheless, symptomatic, giant hemangiomas can be indicated for surgery, embolization or thermoablation. The aim of this study was to define based on our own experience and on the literature when and what treatment option should be indicated in patients suffering from liver hemangioma. METHOD: In the last five years 37 patients with giant hemangiomas indicated for invasive treatment were enrolled in the study. The mean size of the hemangiomas was 67 mm (45-221 mm). Multiple hemangiomas were present in 11 (29.7%) patients. Enucleation was performed in 15 (40.5%), non-anatomical liver resection in three, (8.1%), left lobectomy in one (2.7%) and exploratory laparotomy for a suspected malignant liver tumor in two (5.4%) patients where malignancy was excluded based on contrast enhanced peroperative ultrasonography. Percutaneous transarterial embolization (TAE) was performed in 16 (43.2%) patients. RESULTS: There was zero mortality. A hematoma in the resection line, with spontaneous regression was present in two (10.5%) patients after the surgery. The post-embolization syndrome was presented in three (16.7%) patients after TAE. Progression of the hemangioma was seen in three (28.8%), regression in six (37.5%) patients, and in seven (43.8%) patients the finding remained stable in the interval of 14 years after TAE. CONCLUSION: Conservative approach is can be applied in most liver hemangiomas, especially in small, asymptomatic lesions. Liver surgery is indicated in giant symptomatic or growing hemangiomas with the diameter over 10 cm or in non-specific lesions where the preoperative diagnosis is uncertain. We recommend enucleation as the method of choice, or non-anatomic liver resection. TAE is indicated in high-risk patients and can be repeated if the hemangioma progresses. The use of other methods such as radiofrequency ablation needs to be verified in large clinical studies.Key words: liver hemangiomas - treatment methods.

[Thyroid carcinoma, ten-years file]. / Karcinom stítné zlázy, desetiletý soubor.

INTRODUCTION: Even though thyroid carcinoma has, in general, a good prognosis and low mortality rate, its incidence, especially the incidence of early forms of the disease has been growing. METHOD: Retrospective analysis of the file of surgeries of documented thyroid carcinoma within the years of 2006-2015. RESULTS: Thyroid carcinoma was recorded in 145 of 1820 patients operated for thyreopathy (8%); microcarcinoma (<10mm) was recorded in 64 cases (44.1%). The carcinoma was mostly detected accidentally during total thyroidectomy, which was in 70 cases (48.3%). The carcinoma was expected in 35 cases (24.1%) on the basis of prior puncture and total thyroidectomy was carried out straight away. Perioperative histology after hemithyroidectomy was requested in 31 cases (21.4%), and it was found positive only in 13 cases; thyroidectomy was finished in the second period in the other cases. Due to advanced carcinoma, tumour exploration/debulking was performed in 3 cases (2.1%) - for anaplastic carcinoma in all these cases. A permanent unilateral lesion - n. laryngeus recurrens - occurred in 3 cases (2.1%); a permanent bilateral lesion was recorded twice (1.4%).The most frequently manifested carcinoma was the papillary carcinoma in 114 patients (78.6%; 83 women/31 men; age of 1284 years; mean age of 50.6), the second most frequent carcinoma was the follicular carcinoma in 16 patients (11.0%; 15/1; 1969; 55.3), followed by the medullary carcinoma in 10 patients (6.9%; 6/4; 2576; 58.1). Anaplastic carcinoma was detected only in 4 cases (2.8%; 2/2; 6487; 75.5), and lymphoma of the thyroid gland occurred twice as well as Hürtle cell carcinoma. CONCLUSION: Thyroid carcinoma is mostly found accidentally during surgery in the early phase of the disease. This proves the high quality of endocrinology care and the correctness of the tendency to indicate early surgical treatment of thyroidal pathology.Key words: thyroid carcinoma - thyroidectomy complications.

[Rare malignant tumors of the appendix: surgical treatment of liver metastases case reports]. / Vzácné maligní nádory apendixu: lécba metastáz do jater kazuistiky.

INTRODUCTION: Tumors of appendix vermiformis are quite rare; they represent only about 0.4% of gastrointestinal tract tumors. They can be both benign and malignant (primary or secondary). Carcinoid is the most common tumor of the appendix. The symptoms can include nothing but non-specific abdominal pain, or on the contrary they can imitate inflammatory acute abdomen. Liver metastases are associated with an advanced stage of malignancy; their surgical treatment is presented rarely in the literature. The aim of this publication is to present two cases with different results of surgical treatment of liver metastases with the primary tumor located in the appendix. CASES: The first patient is a 50 years old female who underwent right hepatectomy for liver metastases of Goblet-cell carcinoid of the appendix in 2013 and died six months later due to tumor progression. The second patient is a 58 years old male, still alive, undergoing repeated liver and lung resections and RFA from 2009 due to metastases from appendix carcinoma. CONCLUSION: Examples of dissemination of malignant appendix tumors to the liver need to be evaluated individually. In indicated cases, surgical treatment of liver metastases is justifiable.Key words: tumors of appendix liver metastases surgical treatment.

[Liver metastases of malignant melanoma - utility of resection or radiofrequency ablation]. / Jaterní metastázy maligního melanomu - mají resekce nebo radiofrekvencní ablace smysl?

INTRODUCTION: Incidence of cutaneous and uveal forms of malignant melanoma (MM) has increased significantly in the population in the last years. Biological behavior of both these forms of MM is different and is associated with the development of liver metastases. The prognosis of patients with MM liver metastases is generally poor. The authors seek to consider the sense and the possibilities of surgical treatment of MM liver metastases. METHOD: Seven patients with liver metastases of MM were operated on in the Hepatobiliary Center of the Department of Surgery, University Hospital in Pilsen during the last ten years. Four patients suffered from the uveal and three from the cutaneous form of MM. Mean age of the patients was 58.8 years. R0 liver resection was performed in 3, and radiofrequency ablation in 1 patient. In the remaining 3 patients the operation finished by exploratory laparotomy due to tumor progression. RESULTS: Two patients died in the interval of 6 and 25 months after liver surgery for tumor dissemination. Two patients continue to show disease free survival, currently of 22 and 28 months. CONCLUSION: Liver metastases of MM have a very poor prognosis. Surgical treatment indicated by the multidisciplinary team provides, together with further multimodal treatment, a chance for long-term survival and its indication is justified in selected patients.Key words: malignant melanoma - liver metastases - surgical treatment.

[The Influence of Palliative Chemotherapy on the Quality of Life of Patients with Gastric Cancer]. / Vliv paliativní chemoterapie na kvalitu zivota nemocných s karcinomem zaludku.

BACKGROUND: Gastric cancer is a malignant disease with a poor prognosis. The incidence of gastric cancer in the Czech Republic in 2013 was 14.34 cases per 100,000 citizens. Unfortunately, most patients are dia-gnosed with advanced stage disease and therefore undergo palliative treatment. Some patients undergo surgery and a very small percentage undergo palliative chemotherapy. The five year survival rate for those with advanced gastric cancer ranges from 5-15%. METHODS: This is a prospective study of patients undergoing chemotherapy for advanced gastric cancer. The aim was to assess the quality of life of those undergoing chemotherapy. RESULTS: The results showed that chemotherapy reduced the quality of life for these patients. DISCUSSION: Although palliative chemotherapy prolonged time to progression, it had little impact on overall survival. Conversely, chemotherapy reduced quality of life. Thus, clinicians and patients must decide whether to begin palliative chemotherapy. The final decision should be made by the patient after discussion with the treating clinician. CONCLUSION: Treatment of patients with gastric cancer must be undertaken on an individual basis. Those undergoing palliative treatment must play an active role in the decision process regarding chemotherapy and assess the potential benefits and drawbacks. Because chemotherapy treatment has a detrimental effect on quality of life, the decision should be based on factors that predict the likely therapeutic effect of chemotherapy. A definitive decision can then be made as to whether chemotherapy is indicated. KEY WORDS: gastric cancer - palliative chemotherapy - chemotherapy - quality of life - WHOQOL-BREFThis study was supported by grant of Internal Grant Agency of the Czech Ministry of Health No. NS14227-3.The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.The Editorial Board declares that the manuscript met the ICMJE recommendation for biomedical papers.Submitted: 10. 1. 2016Accepted: 8. 6. 2016.

[Predictive and prognostic factors of gastric cancer]. / Prediktivní a prognostické faktory karcinomu zaludku.

INTRODUCTION: Gastric cancer is a frequent malignant disease with poor prognosis. Most patients undergo only palliative treatment. Chemotherapy is another alternative but its effect differs in individual patients. METHOD: This is retrospective study. We enrolled 54 patients (N=54) according to the inclusion criteria. We performed quantification of gene expression of selected genes and some microRNA from tumour tissue, which was used for the diagnosis. Statistical analysis of the data was performed. RESULTS: We demonstrated a predictive value of gene expression of thynidylate synthase in tumour tissue for a therapeutic effect of chemotherapy based on 5-Fluorouracil or Capecitabine. At the same time, we demonstrated a predictive value of miR181, miR150, mir192 and miR342 microRNA levels from the tumour tissue. In addition, we succeeded to demonstrate a predictive value of miR221, miR224, miR520 and miR375 microRNA levels for a therapeutic effect of chemotherapy based on platinum derivates. CONCLUSION: Thanks to the use of efficient therapy predictors, we can distinguish those patients who will profit from chemotherapy from patients where an effect cannot be expected. Thanks to personified oncology therapy the quality of life of some patients can be improved while reducing the costs of the therapy by avoiding inefficient chemotherapy. Only an early diagnosis of gastric cancer can reverse the adverse prognosis of patients with this disease. KEY WORDS: gastric cancer - microRNA - prognostic markers - predictive markers.

[Comparison of percutaneous and open approach to radiofrequency ablation of colorectal liver metastases in Teaching Hospital Pilsen in 20012015]. / Porovnání perkutánní a otevrené radiofrekvencní ablace metastáz kolorektálního karcinomu ve FN Plzen v letech 20012015.

INTRODUCTION: Radiofrequency ablation (RFA) is a well-established method for palliative therapy of unresectable liver tumors. We use an open or percutaneous approach for the treatment of colorectal liver metastases (CLM). METHOD: Clinical data of patients undergoing percutaneous or open RFA for CLM between January 2001 and January 2015 were included in the retrospective study. We evaluated clinical factors for overall survival (OS), no evidence of disease (NED) and non-ablation in relation to tumor sizes and numbers, type of approach and type of used probes. RESULTS: 147 patients underwent RFA for CLM in this time period. Mean age was 65 years. 168 RFAs were performed in total. OS was influenced by a high number of censors. OS for the first and third years was 93.6% and 61% with no statistical differences between the percutaneous and open approach. NED was significantly shorter in patients with the percutaneous approach. NED was not influenced neither by size nor number of the lesions. A higher risk of non-ablation was observed as statistically significant in patients with percutaneous RFA. A higher, although not statistically significant, risk of non-ablation was also observed for larger metastases. Patients with percutaneous RFA showed a shorter stay in the hospital and fewer complications. CONCLUSION: RFA is an alternative approach to the treatment of unresectable CLM. In our study the open approach was associated with a lower risk of non-ablation. Percutaneous RFA showed a lower risk of complications and a shorter stay in the hospital. KEY WORDS: radiofrequency ablation percutaneous RFA colorectal liver metastases CLM palliative therapy.

[Granulomatous inflammation in differential diagnosis of hepatobiliary malignancy]. / Granulomatózní zánety v diferenciální diagnostice malignit hepatobiliárního traktu - kazuistiky.

UNLABELLED: The authors present two case reports to demonstrate wide differential diagnosis of granulomatous disorders of the hepatobiliary tract. Isolated granulomatous disorders are very rare in this area. Differantial diagnosis includes infectious and systemic diseases or chemical irritation. Granulomas often immitate malignant tumors and the surgeon could be first to diagnose this disease during liver resection or cholecystectomy. KEY WORDS: granulomatous inflammation hepatic granuloma non-specific inflammation liver resection cholecystectomy.

[Liver metastases from colon and rectal cancer in terms of differences in their clinical parameters]. / Jaterní metastázy karcinomu kolon a rekta z pohledu rozdílu v klinických parametrech.

INTRODUCTION: From the clinical point of view, rectal cancer and colon cancer are clearly different nosological units in their progress and treatment. The aim of this study was to analyse and clarify the differences between the behaviour of liver metastases from colon and rectal cancer. The study of these factors is important for determining an accurate prognosis and indication of the most effective surgical therapy and oncologic treatment of colon and rectal cancer as a systemic disease. METHOD: 223 patients with metastatic disease of colorectal carcinoma operated at the Department of Surgery, University Hospital in Pilsen between January 1, 2006 and January 31, 2012 were included in our study. The group of patients comprised 145 men (65%) and 117 women (35%). 275 operations were performed. Resection was done in 177 patients and radiofrequency ablation (RFA) in the total of 98 cases. Our sample was divided into 3 categories according to the location of the primary tumor to C (colon), comprising 58 patients, S (c. sigmoideum) in 61 patients, and R (rectum), comprising 101 patients. Significance analysis of the studied factors (age, gender, staging [TNM classification], grading, presence of mucinous carcinoma, type of operation) was performed using ANOVA test. Overall survival (OS), disease-free interval (DFI) or no evidence of disease (NED) were estimated using Kaplan-Meier curves, which were compared with the log-rank and Wilcoxon tests. RESULTS: As regards the comparison of primary origin of colorectal metastases in liver regardless of their treatment (resection and RFA), our study indicated that rectal liver metastases showed a significantly earlier recurrence than colon liver metastases (shorter NED/DFI). Among other factors, a locally advanced finding, further R2 resection of liver metastases and positivity of lymph node metastases were statistically significant for the prognosis of an early recurrence of the primary colon and sigmoid tumor. Furthermore, we proved that in patients with primary rectal carcinoma, DFI (after the resection of liver metastases) was not influenced by the positivity of lymph node metastases of primary tumor or locally advanced primary tumor. The other factors studied (time from diagnosis of organ metastases to primary operation, grading, sex or age) were not shown to be statistically significant for the prognosis of OS and DFI (colorectal cancer in total). CONCLUSION: As proven by our study, rectal cancer and colon cancer are two different nosological units with specific prognostic factors with respect to their liver metastases. These differences have not been fully understood yet and require further exploration and classification based not only on histopathological, immunohistochemical and clinical factors, but also on molecular biological parameters. KEY WORDS: colon carcinoma metastases rectal carcinoma metastases prognostic factors overall survival - liver metastases.

Surgical treatment of gastric cancer.

UNLABELLED: Gastric cancer is a malignant disease which has generally a very bad prognosis. The frequency of occurence of this disease in the population is dependent on the age and localisation. Most frequently, this disease has occured in Japan, China, countries of South Africa and Eastern Europe for a long time but men are more likely to suffer from this disease than women witha ratio of 2 : 1. METHODS: We retrospectively evaluated the group of patients who had been treated in our complex oncology center in the course of five years RESULTS: We treated 572 patients with gastric cancer in five years period. 218 patients of the total number were admitted, 185 patients of all hospitalized patients were operated (85 %). 53 patients of our group of hospitalized patients underwent adjuvant oncology therapy (24 %). Overall, five-year survival was 18.4 % in our group, the median survival time was 12.9 months. CONCLUSION: Radical surgery is considered to be the only treatment modality which can lead to patient´s cure under optimal conditions. Complex care for patients with gastric carcinoma should be centralized in big centers. Personalized oncological treatment should be a way how to get better results (Tab. 2, Fig. 5, Ref. 14).

[Colorectal liver metastases surgery - the present and the perspectives]. / Resekce jater pro metastázy kolorektálního karcinomu - soucasnost a perspektivy.

The incidence of colorectal liver metastases (CLM) in the fourth stage of colorectal carcinoma is 80%, liver parenchyma only being impaired in 40% of patients. Liver resection is the "gold standard" of treatment with long-term overall survival. However, only 20-25% of CLM are primarily resectable. Many staged procedures exist for increasing secondary CLM resectability - modern oncologic therapy, portal vein embolization, stem cells application, ALPPS (associating liver partition and portal vein ligation for staged hepatectomy), sequential liver procedures, combined resections with thermoablation procedures. Perioperative oncological therapy in primary resectable CLM is currently recommended. The patients prognosis depends on the biological CLM activity, which is evaluated according to several serum or histopathological markers. Resectable extrahepatic metastases are no more a contraindication for liver resection. One-stage resection of primary tumour and CLM is recommended in cases where one procedure is simple and short. Liver first procedure can be used in patients with the risk of non-resectability of advanced CLM after the treatment of primary colorectal cancer. Up to 55-60% of patients will develop recurrent CLM which are resectable in many cases, or thermoablation methods can be used.